Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lannett Co. Inc.

www.lannett.com

Latest From Lannett Co. Inc.

Sandoz Will Not Pursue US Advair Rival

Sandoz has decided to discontinue development of its generic version of GlaxoSmithKline’s Advair Diskus respiratory brand, resulting in an impairment charge of $442m.

Strategy Generic Drugs

Lannett To Launch Into Congested ADHD Market

Lannett expects soon to launch a generic rival to Adderall XR following FDA approval for its partner SunGen. But the US generics specialist will face considerable competition.

Launches Neurology

Lannett Reports Insulin Glargine Trial Success

Lannett’s Phase I trial for biosimilar insulin glargine has met “all primary endpoints,” the company has announced. The rival to Sanofi’s Lantus is being developed by Lannett with partner HEC through a deal for which financial details have just been revealed.

Biosimilars United States

Direct Seller's CBD Supplement Recall Mandated, More Ranitidine, Tween Cosmetic Recalls

FDA's latest recalls records update includes Basic Reset CBD supplements and another 4,300 units of Tween Brands cosmetics containing colors made from banned dye. Recalls resulting from testing of ranitidine drugs reported by Dr. Reddy's.

Recalls OTC Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Lannett Co. Inc.
  • Senior Management
  • Timothy C Crew, CEO
    Martin P Galvan, VP, Fin. & CFO
    Kristin Arnold, VP, R&D
    Alicia Evolga, VP, Mktg.
  • Contact Info
  • Lannett Co. Inc.
    Phone: (215) 333-9000
    9000 State Rd.
    Philadelphia, PA 19136
    USA
UsernamePublicRestriction

Register